Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient ...

Danaher Corp. closed 34.49% below its 52-week high of $281.70, which the company achieved on August 1st.

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

Shares of Danaher Corp. slipped 5.54% to $186.81 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.61% to 5,844.61 and Dow Jones ...

Vietnam emerges as the fastest-growing market, bolstered by strong primary healthcare enhancements. The infectious disease testing segment is set to ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other billionaire Lei Zhang’s stock picks with huge upside potential. Lei Zhang, the founder ...

The global Digital Pathology Market, valued at US$1.29 billion in 2024 stood at US$1.46 billion in 2025 and is projected to ...

In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discusses. Back in 2024, on May 15, Mad Money’s Jim Cramer ...

The new SCIEX OS software version 4.0 is the latest evolution of its powerful software platform. This new Microsoft Windows 11 compatible release drives operability enhancements with speed and ...

We're joined by Danaher. I'm joined by Rainer Blair, CEO. Rainer thanks so much for being here. Last session of the conference, but certainly not last but not least, I also want to thank everyone ...